See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Thalia Field

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	41134247	0	Zhou LW, Dizonno V, Mandzia J, et al. Multiple Health Care Encounters Prior to Diagnosis of Cerebral Venous Thrombosis. Ann Emerg Med. 2025 Oct 23:S0196-0644(25)01234-X. doi: 10.1016/j.annemergmed.2025.09.020.
	41058375	0	Chui C, Sun T, Mousavi M, et al. Feasibility of perioperative stroke screening tools in cardiac surgery patients: a prospective observational pilot study. Br J Anaesth. 2025 Oct 6:S0007-0912(25)00623-3. doi: 10.1016/j.bja.2025.08.053.
	40432320	0	Field TS, Aaron S, Chetty S, et al. Cerebral Venous Thrombosis: Selected Persisting Areas of Uncertainty. Ann Indian Acad Neurol. 2025 May 27. doi: 10.4103/aian.aian_162_25.
	40143807	0	Mandel DM, Shu L, Chang C, et al. Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection. Stroke. 2025 Jun;56(6):1413-1421. doi: 10.1161/STROKEAHA.124.048215. Epub 2025 Mar 27.
	39986294	0	Garcia Guarniz AL, Field TS, Yaghi S. Direct oral anticoagulants for cerebral venous thrombosis. Lancet Neurol. 2025 Mar;24(3):180-181. doi: 10.1016/S1474-4422(25)00035-3.
	39862882	0	Shoamanesh A, Field TS, Coutts SB, et al. Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial. Lancet Neurol. 2025 Feb;24(2):140-151. doi: 10.1016/S1474-4422(24)00475-7.
	39801061	0	Waheed Z, Field TS, Zhou LW. Health Care Encounters Prior to Hospitalization for Cerebral Venous Thrombosis Patients - ERRATUM. Can J Neurol Sci. 2025 Jan 13:1. doi: 10.1017/cjn.2024.363.
	39788764	0	Cimen E, Ng K, Buck BH, et al. Importance of infarct topography in determination of stroke mechanism and recurrence risk: a post-hoc analysis of the dabigatran acute treatment of stroke trial. BMJ Open. 2025 Jan 9;15(1):e087704. doi: 10.1136/bmjopen-2024-087704.
	39781748	0	Perera KS, Sharma MA, Eikelboom JW, et al. Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease. Stroke. 2025 Feb;56(2):380-389. doi: 10.1161/STROKEAHA.124.047715. Epub 2025 Jan 9.
	39639491	0	Field TS, Lindsay MP, Wein T, et al. Canadian Stroke Best Practice Recommendations, 7th Edition: Cerebral Venous Thrombosis, 2024 - CORRIGENDUM. Can J Neurol Sci. 2024 Dec 6:1. doi: 10.1017/cjn.2024.350.
	39569543	0	Brakel BA, Rebchuk AD, Ospel J, et al. International practice patterns and perspectives on endovascular therapy for the treatment of cerebral venous thrombosis. Int J Stroke. 2024 Nov 21:17474930241304206. doi: 10.1177/17474930241304206.
	39523979	0	Field TS, Shu L, Kim DJ, et al. Lead-In Parenteral Anticoagulation Prior to Direct Oral Anticoagulation for Cerebral Venous Thrombosis. Can J Neurol Sci. 2024 Nov 11:1-6. doi: 10.1017/cjn.2024.325.
	39229707	0	McIntyre WF, Benz AP, Healey JS, et al. Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial. Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069903.
	39211760	0	Holodinsky JK, Kumar M, McNaughton CD, et al. An Interrupted Time-Series Analysis of the Impact of COVID-19 on Hospitalizations for Vascular Events in 3 Canadian Provinces. CJC Open. 2024 Apr 30;6(8):959-966. doi: 10.1016/j.cjco.2024.04.010. eCollection 2024 Aug.
	38847098	0	Yaghi S, Shu L, Fletcher L, et al. Anticoagulation Versus Antiplatelets in Spontaneous Cervical Artery Dissection: A Systematic Review and Meta-Analysis. Stroke. 2024 Jul;55(7):1776-1786. doi: 10.1161/STROKEAHA.124.047310. Epub 2024 Jun 7.
	38843785	0	Ospel JM, Singh N, Nguyen TN, et al. Endovascular therapy for cerebral venous thrombosis: Applying lessons learned from clinical trials of EVT in acute arterial ischemic stroke. Cerebrovasc Dis. 2024 Jun 6. doi: 10.1159/000539657.
	38836280	0	Shoskes A, Shu L, Nguyen TN, et al. Prevalence and Associations of Dural Arteriovenous Fistulae in Cerebral Venous Thrombosis: Analysis of ACTION-CVT. J Stroke. 2024 May;26(2):325-329. doi: 10.5853/jos.2023.02264. Epub 2024 May 30.
	38830225	0	Field TS. In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin. Ann Intern Med. 2024 Jun;177(6):JC65. doi: 10.7326/ANNALS-24-00436-JC. Epub 2024 Jun 4.
	38826076	0	Field TS, Lindsay MP, Wein T, et al. Canadian Stroke Best Practice Recommendations, 7(th) Edition: Cerebral Venous Thrombosis, 2024. Can J Neurol Sci. 2024 Jun 3:1-57. doi: 10.1017/cjn.2024.269.
	38614162	0	Klein P, Shu L, Lindgren E, et al. External Validation of the SI(2)NCAL(2)C Score for Outcomes Following Cerebral Venous Thrombosis. J Stroke Cerebrovasc Dis. 2024 Apr 11:107720. doi: 10.1016/j.jstrokecerebrovasdis.2024.107720.
	38606547	0	Waheed Z, Field TS, Zhou LW. Health Care Encounters Prior to Hospitalization for Cerebral Venous Thrombosis Patients. Can J Neurol Sci. 2024 Apr 12:1-20. doi: 10.1017/cjn.2024.48.
	38508830	0	Sposato LA, Andrade JG, Field TS. Detection of atrial fibrillation in patients after stroke - Authors' reply. Lancet Neurol. 2024 Apr;23(4):336-337. doi: 10.1016/S1474-4422(24)00088-7.
	38494462	0	Coutinho JM, van de Munckhof A, Aguiar de Sousa D, et al. Reducing the global burden of cerebral venous thrombosis: an international research agenda. Int J Stroke. 2024 Mar 17:17474930241242266. doi: 10.1177/17474930241242266.
	38408574	0	Klein P, Shu L, Qureshi MM, et al. Trends in Cerebral Venous Thrombosis Before and During the COVID-19 Pandemic: Analysis of the National Inpatient Sample. J Stroke Cerebrovasc Dis. 2024 Feb 24:107651. doi: 10.1016/j.jstrokecerebrovasdis.2024.107651.
	38335240	0	Yaghi S, Shu L, Mandel D, et al. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study. Stroke. 2024 Apr;55(4):908-918. doi: 10.1161/STROKEAHA.123.045731. Epub 2024 Feb 9.
	38326711	0	Nguyen TN, Qureshi MM, Klein P, et al. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. J Stroke. 2024 Jan;26(1):129. doi: 10.5853/jos.2022.00752.e1. Epub 2024 Jan 30.
	38284265	0	Saposnik G, Bushnell C, Coutinho JM, et al. Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association. Stroke. 2024 Jan 29. doi: 10.1161/STR.0000000000000456.
	38081629	0	Hennawy M, Zhou LW, Field TS. Cerebral venous thrombosis should be considered in a postpartum patient with headache and seizure. CMAJ. 2023 Dec 10;195(48):E1663. doi: 10.1503/cmaj.149620.
	38056405	0	Zhou LW, Hennawy M, Ngo L, et al. Prognosis after cerebral venous thrombosis: Mortality during initial admission and at 30 days and one year after discharge in a large Canadian population-based cohort. Thromb Res. 2023 Nov 26;233:145-152. doi: 10.1016/j.thromres.2023.11.028.
	37839436	0	Sposato LA, Field TS, Schnabel RB, et al. Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack. Lancet Neurol. 2023 Oct 11:S1474-4422(23)00326-5. doi: 10.1016/S1474-4422(23)00326-5.
	37771138	0	Weller J, Krzywicka K, van de Munckhof A, et al. Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Eur Stroke J. 2023 Sep 28:23969873231202363. doi: 10.1177/23969873231202363.
	37675613	0	Field TS, Dizonno V, Almekhlafi MA, et al. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis. Stroke. 2023 Sep 7. doi: 10.1161/STROKEAHA.123.044113.
	37459107	0	Rebchuk AD, Hill MD, Goyal M, et al. Exploring sex differences for acute ischemic stroke clinical, imaging and thrombus characteristics in the INTERRSeCT study. J Cereb Blood Flow Metab. 2023 Oct;43(10):1803-1809. doi: 10.1177/0271678X231189908. Epub 2023 Jul 17.
	37434312	0	Scutelnic A, van de Munckhof A, Krzywicka K, et al. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19. Eur Stroke J. 2023 Jul 11:23969873231185213. doi: 10.1177/23969873231185213.
	37397616	0	Gilhofer TS, Nestelberger T, Kang M, et al. Stroke Prevention With Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Prior Intracranial Hemorrhage. CJC Open. 2023 Mar 10;5(6):404-411. doi: 10.1016/j.cjco.2023.03.004. eCollection 2023 Jun.
	37277922	0	van de Munckhof A, Borhani-Haghighi A, Aaron S, et al. Cerebral Venous Sinus Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia in Middle-Income Countries. Int J Stroke. 2023 Jun 5:17474930231182901. doi: 10.1177/17474930231182901.
	37168399	0	Kim DJ, Honig A, Alimohammadi A, et al. Recanalization and outcomes after cerebral venous thrombosis: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2023 Apr 3;7(3):100143. doi: 10.1016/j.rpth.2023.100143. eCollection 2023 Mar.
	36907985	0	Alrohimi A, Rose DZ, Burgin WS, et al. Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trials. Int J Stroke. 2023 Aug;18(7):864-872. doi: 10.1177/17474930231164891. Epub 2023 Mar 26.
	36773014	0	Krzywicka K, Aguiar de Sousa D, Cordonnier C, et al. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Eur J Neurol. 2023 Feb 11. doi: 10.1111/ene.15735.
	36337058	0	Zhou LW, Yu AYX, Ngo L, et al. Incidence of Cerebral Venous Thrombosis: A Population-Based Study, Systematic Review, and Meta-Analysis. Stroke. 2022 Nov 7. doi: 10.1161/STROKEAHA.122.039390.
	36212651	0	Heldner MR, Aguiar de Sousa D, Field TS, et al. Editorial: Cerebral venous thrombosis. Front Neurol. 2022 Sep 23;13:1021547. doi: 10.3389/fneur.2022.1021547. eCollection 2022.
	36082668	0	van de Munckhof A, Lindgren E, Kleinig TJ, et al. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase. Stroke. 2022 Sep 9:101161STROKEAHA122039575. doi: 10.1161/STROKEAHA.122.039575.
	35938419	0	Yaghi S, Saldanha IJ, Misquith C, et al. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke. 2022 Aug 8:101161STROKEAHA122039579. doi: 10.1161/STROKEAHA.122.039579.
	35689346	0	Scutelnic A, Krzywicka K, Mbroh J, et al. Management of cerebral venous thrombosis due to adenoviral COVID-19 vaccination. Ann Neurol. 2022 Jun 10. doi: 10.1002/ana.26431.
	35677980	0	Nguyen TN, Qureshi MM, Klein P, et al. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. J Stroke. 2022 May;24(2):256-265. doi: 10.5853/jos.2022.00752. Epub 2022 May 31.
	35611694	0	Chang SJ, Rebchuk AD, Teal P, et al. COVID-19-Associated Cerebral Developmental Venous Anomaly Thrombosis With Hemorrhagic Transformation. Stroke. 2022 May 25:101161STROKEAHA122039534. doi: 10.1161/STROKEAHA.122.039534.
	35491501	0	Sposato LA, Field TS. Atrial fibrillation detection after stroke: Is all created equal? Eur J Neurol. 2022 Jul;29(7):1869-1870. doi: 10.1111/ene.15375. Epub 2022 May 8.
	35201292	0	Lee AY, Al Moosawi M, Peterson EA, et al. Clinical Care Pathway for Suspected Vaccine-Induced Immune Thrombotic Thrombocytopenia After ChAdOx1 nCoV-19 vaccination. Blood Adv. 2022 Feb 24. pii: 484151. doi: 10.1182/bloodadvances.2021006862.
	35143324	0	Gorman JB, Field TS. ACTION-CVT: Are the Findings ACTIONable? Stroke. 2022 Feb 10:STROKEAHA122038564. doi: 10.1161/STROKEAHA.122.038564.
	35100023	0	Rivard L, Friberg L, Conen D, et al. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. Circulation. 2022 Feb;145(5):392-409. doi: 10.1161/CIRCULATIONAHA.121.055018. Epub 2022 Jan 31.
	35028817	0	Alimohammadi A, Kim DJ, Field TS. Updates in Cerebral Venous Thrombosis. Curr Cardiol Rep. 2022 Jan 13. pii: 10.1007/s11886-021-01622-z. doi: 10.1007/s11886-021-01622-z.
	34921078	0	Nasreen S, Calzavara AJ, Sundaram ME, et al. Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study. BMJ Open. 2021 Dec 17;11(12):e052019. doi: 10.1136/bmjopen-2021-052019.
	34645539	0	Zhou LW, Yu AYX, Hall W, et al. Validity of ICD 10 Codes for Cerebral Venous Thrombosis Depends on Clinical Context. Can J Neurol Sci. 2021 Oct 14:1-10. doi: 10.1017/cjn.2021.235.
	34581763	0	Sanchez van Kammen M, Aguiar de Sousa D, Poli S, et al. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurol. 2021 Sep 28. pii: 2784622. doi: 10.1001/jamaneurol.2021.3619.
	34510039	0	Plecash AR, Byrne D, Flexman A, et al. Stroke in Patients with Left Ventricular Assist Devices. Cerebrovasc Dis. 2021 Sep 10:1-11. doi: 10.1159/000517454.
	34213527	0	Sanchez van Kammen M, Heldner MR, Brodard J, et al. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA. 2021 Jul 27;326(4):332-338. doi: 10.1001/jama.2021.9889.
	33639297	0	Healey JS, Roberts JD, Field TS. Who is at risk of atrial fibrillation? Heart Rhythm. 2021 Jun;18(6):853-854. doi: 10.1016/j.hrthm.2021.02.019. Epub 2021 Feb 24.
	33074284	0	Shoamanesh A, Hart RG, Connolly SJ, et al. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial. JAMA Neurol. 2021 Jan 1;78(1):11-20. doi: 10.1001/jamaneurol.2020.3836.
	32576089	0	Lu N, Smith JMC, Andrade JG, et al. Considerations in Adult Congenital Heart Disease and Stroke: A Case Report. Stroke. 2020 Aug;51(8):e148-e150. doi: 10.1161/STROKEAHA.119.028605. Epub 2020 Jun 24.
	32369855	0	Giustozzi M, Curcio A, Weijs B, et al. Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer. Thromb Haemost. 2020 May;120(5):847-856. doi: 10.1055/s-0040-1709527. Epub 2020 May 5.
	32098609	0	Butcher KS, Ng K, Sheridan P, et al. Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke. Stroke. 2020 Apr;51(4):1190-1198. doi: 10.1161/STROKEAHA.119.027569. Epub 2020 Feb 26.
	31809335	0	Healey JS, Amit G, Field TS. Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke? Curr Opin Neurol. 2020 Feb;33(1):17-23. doi: 10.1097/WCO.0000000000000780.
	31186132	0	Field TS. Recurrent venous thromboembolism after cerebral venous thrombosis: which lower-risk survivors are at risk for recurrence? Thromb Res. 2019 Oct;182:182-183. doi: 10.1016/j.thromres.2019.05.015. Epub 2019 May 31.
	31092159	0	Field TS, Hill MD. Cerebral Venous Thrombosis. Stroke. 2019 Jun;50(6):1598-1604. doi: 10.1161/STROKEAHA.119.025334. Epub 2019 May 16.
	30919384	0	Field TS, Weijs B, Curcio A, et al. Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study. Thromb Haemost. 2019 Jun;119(6):981-991. doi: 10.1055/s-0039-1683429. Epub 2019 Mar 27.
	29574430	0	Funnell C, Heran MKS, Teal P, et al. Rapidly expanding venous intracerebral haemorrhage with spot sign. BMJ Case Rep. 2018 Mar 23;2018. pii: bcr-2017-223055. doi: 10.1136/bcr-2017-223055.
	28585903	0	Ng KH, Sharma M, Benavente O, et al. Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II). Int J Stroke. 2017 Oct;12(8):910-914. doi: 10.1177/1747493017711947. Epub 2017 Jun 6.
	27809948	0	Field TS, Camden MC, Al-Shimemeri S, et al. Antithrombotic Strategy in Cerebral Venous Thrombosis: Differences Between Neurologist and Hematologist Respondents in a Canadian Survey. Can J Neurol Sci. 2017 Jan;44(1):116-119. doi: 10.1017/cjn.2016.297. Epub 2016 Nov 4.
	26763915	0	Field TS, Camden MC, Al-Shimemeri S, et al. Off-label use of novel anticoagulants for treatment of cerebral venous thrombosis: A Canadian survey. Int J Stroke. 2017 Dec;12(9):NP16-NP18. doi: 10.1177/1747493015616643. Epub 2016 Jan 12.
	25883570	0	Andrade JG, Field T, Khairy P. Detection of occult atrial fibrillation in patients with embolic stroke of uncertain source: a work in progress. Front Physiol. 2015 Apr 1;6:100. doi: 10.3389/fphys.2015.00100. eCollection 2015.